- Posts by Kelsey J. McElveen
OfficerAs a member of the firm’s Intellectual Property Litigation group, Kelsey focuses her practice on patent litigation under the Hatch-Waxman Act. After nearly a decade of experience working on Abbreviated New Drug Application ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventHealth Law Webinar—The Latest Federal Health Privacy Regulations: Explaining the New Substance Use Disorder Patient Records and HIPAA Final Rules
- EventWomen of Color in the Law: Lifting as We Climb
- Legal UpdateGovernor Reynolds Signs Three New Laws Affecting the Real Estate and Leasing Industries
- Legal UpdateHigher Immigration Fees Took Effect April 1